VivoSeq
Other

Tobacco Dependence

1

Pipeline Programs

1

Active Trials

0

Companies Involved

Tobacco Dependence is an early-stage landscape with 1 program across 0 companies. 1 therapy is approved.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

14/100

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

7

clinical trials

Completed5 · 71%
Terminated1 · 14%
Active, not recruiting1 · 14%

Trial Activity

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)